Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 59.11 -1.31 (2.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.42 | 52 Week High | $0.52 | |||
| Open | $60.33 | 52 Week Low | $0.08 | |||
| Day High | $61.52 | P/E | N/A | |||
| Day Low | $57.91 | EPS | $-3.80 | |||
| Volume | 943,163 | |||||
